logo-loader
NYSE:AGE

AgeX Therapeutics

Receive alerts
Market:
NYSE
Market Cap:
$33.44 m
Price
0.89 USD
Change
2.58%
52 weeks high
3.36
52 weeks low
0.72

In brief

AgeX Therapeutics is focused on the development and commercialization of novel therapeutics targeting human aging. We are building upon the foundation of our proprietary technologies such as PureStem® and induced Tissue Regeneration (iTR™) to develop innovative medicines designed to address some of the largest unsolved problems in aging. Through PureStem® we have the ability to generate pluripotent stem cell-derived young cells of any type for potential application in a range of degenerative diseases of aging with a high unmet medical need. iTR™ is our revolutionary longevity platform aiming to unlock cellular immortality and regenerative capacity to reverse age-related changes in the body.